My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

176.19 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,146
Open 176.19
Bid (Size) 175.59 (1)
Ask (Size) 176.22 (1)
Prev. Close 176.19
Today's Range 176.19 - 176.19
52wk Range 140.68 - 181.16
Shares Outstanding 2,628,679,824
Dividend Yield 2.95%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kenvue, J&J Retail Traders Cautious As US Health Officials Reportedly Plan To Announce Tylenol Links To Autism
Tylenol is one of the most common medicines for reducing pain and fever, and a major product for Kenvue. 
Via Stocktwits
Topics Government
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
The trillion-dollar club will probably need to make room for at least one Dividend King in the coming years. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+22.3%
+22.3%
1 Month
-1.7%
-1.7%
3 Month
+16.4%
+16.4%
6 Month
+7.9%
+7.9%
1 Year
+7.9%
+7.9%

More News

Read More
Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits
Via Benzinga
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill
Via The Motley Fool
Topics Intellectual Property
J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study
Via Stocktwits
Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements
Via MarketMinute
Topics Bankruptcy Death Lawsuit
P&G's Q3 2025: Sales Miss Overshadows Earnings Beat Amidst Global Headwinds
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era
Via MarketMinute
Lilly's $5 Billion Virginia Investment: A Game Changer for GLP-1 and Oncology Drug Production
Via MarketMinute
Topics Artificial Intelligence Economy Government
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
Via MarketMinute
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Via Benzinga
Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J?
Via Investor's Business Daily
Recent Report Shows That Rep. Thomas Kean Bought Up to $45K Worth of Amcor Stock
Via Benzinga
8 Dividend Growth Stocks Every Investor Should Consider
Via The Motley Fool
Topics Artificial Intelligence Economy
Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday
Via Benzinga
Intuitive Surgical: A Steady Hand in a Storm of AI Hype?
Via MarketMinute
Topics Artificial Intelligence Supply Chain
Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot
Via MarketMinute
Topics Economy Supply Chain World Trade
What the Options Market Tells Us About Johnson & Johnson
Via Benzinga
The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials
Via Benzinga
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Via MarketMinute
Topics Artificial Intelligence Supply Chain
A Precarious Ascent: Stock Market Bulls Grapple with Stubborn Inflation and a Cooling Job Market
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson (NYSE:JNJ): A Dividend Stock with Lasting Financial Strength
Via Chartmill
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America
Via Stocktwits
Topics Artificial Intelligence Government World Trade
Navigating the Storm: Investment Strategies for an Unpredictable 2025
Via MarketMinute
Topics Artificial Intelligence Bonds Climate Change

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 176.19
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 09/19/25 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 463.15B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 463B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.